Moreover, a survival analysis conducted on the TCGA-LAML dataset within the GEPIA2 platform revealed a noteworthy association between elevated FOXD2-AS1 expression levels and a marked reduction in the OS of patients diagnosed with AML. Here, FOXD2 is linked to acute myeloid leukemia.